Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

Ketamine was first approved by the FDA as an anaesthetic in the 1970s and has been used for a long time in emergency and surgical settings. In 2019, esketamine (Spravato), derived from ketamine ...

Cybin (CYBN) stock earns Guggenheim's Buy rating with a $35 target, as the firm cites blockbuster potential for CYB003 in line with J&J's (JNJ) Spravato. Read more here.

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

They also note that the oral tablets would be less prone to abuse and diversion than other ketamine formulations. They could also be cheaper, given that Spravato's US list price in the US is $590 ...

Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.

Monica Riggs is a Board-Certified Psychiatric Mental Health Nurse Practitioner (PMHNP-BC), certified through the American Nurses Credentialing Center (ANCC). She brings 17 years of medical ...